Return On Equity of Xilio Therapeutics, Inc. from 31 Dec 2020 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Xilio Therapeutics, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2020 to 30 Sep 2025.
  • Xilio Therapeutics, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -858%, a 299% decline year-over-year.
  • Xilio Therapeutics, Inc. annual Return On Equity for 2024 was -238%, a 88% decline from 2023.
  • Xilio Therapeutics, Inc. annual Return On Equity for 2023 was -127%, a 94% decline from 2022.
  • Xilio Therapeutics, Inc. annual Return On Equity for 2022 was -65%, a 137% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Xilio Therapeutics, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -858% -643% -299% 01 Jul 2025 30 Sep 2025
Q2 2025 -399% -223% -126% 01 Apr 2025 30 Jun 2025
Q1 2025 -263% -107% -69% 01 Jan 2025 31 Mar 2025
Q4 2024 -238% -112% -88% 01 Oct 2024 31 Dec 2024
Q3 2024 -215% -110% -105% 01 Jul 2024 30 Sep 2024
Q2 2024 -177% -89% -101% 01 Apr 2024 30 Jun 2024
Q1 2024 -156% -78% -100% 01 Jan 2024 31 Mar 2024
Q4 2023 -127% -61% -94% 01 Oct 2023 31 Dec 2023
Q3 2023 -105% -50% -91% 01 Jul 2023 30 Sep 2023
Q2 2023 -88% +3.4% +3.8% 01 Apr 2023 30 Jun 2023
Q1 2023 -78% +266% +77% 01 Jan 2023 31 Mar 2023
Q4 2022 -65% -242% -137% 01 Oct 2022 31 Dec 2022
Q3 2022 -55% -125% -179% 01 Jul 2022 30 Sep 2022
Q2 2022 -91% -173% -211% 01 Apr 2022 30 Jun 2022
Q1 2022 -343% -430% -496% 01 Jan 2022 31 Mar 2022
Q4 2021 177% +82% +86% 01 Oct 2021 31 Dec 2021
Q3 2021 70% 01 Jul 2021 30 Sep 2021
Q2 2021 82% 01 Apr 2021 30 Jun 2021
Q1 2021 87% 01 Jan 2021 31 Mar 2021
Q4 2020 95% 01 Oct 2020 31 Dec 2020

Xilio Therapeutics, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -238% -112% -88% 01 Jan 2024 31 Dec 2024
2023 -127% -61% -94% 01 Jan 2023 31 Dec 2023
2022 -65% -242% -137% 01 Jan 2022 31 Dec 2022
2021 177% +82% +86% 01 Jan 2021 31 Dec 2021
2020 95% 01 Jan 2020 31 Dec 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.